Skip to main content
The BMJ logoLink to The BMJ
letter
. 1989 Oct 7;299(6704):916.

Follicular stimulation: is it safe?

PMCID: PMC1837774  PMID: 2510887

Full text

PDF

Page 916

916

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cramer D. W., Welch W. R. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst. 1983 Oct;71(4):717–721. [PubMed] [Google Scholar]
  2. Fishel S., Jackson P. Follicular stimulation for high tech pregnancies: are we playing it safe? BMJ. 1989 Jul 29;299(6694):309–311. doi: 10.1136/bmj.299.6694.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Graves P. E., Surwit E. A., Davis J. R., Stouffer R. L. Adenylate cyclase in human ovarian cancers: sensitivity to gonadotropins and nonhormonal activators. Am J Obstet Gynecol. 1985 Dec 15;153(8):877–882. doi: 10.1016/0002-9378(85)90693-3. [DOI] [PubMed] [Google Scholar]
  4. Heintz A. P., Hacker N. F., Lagasse L. D. Epidemiology and etiology of ovarian cancer: a review. Obstet Gynecol. 1985 Jul;66(1):127–135. [PubMed] [Google Scholar]
  5. Mohle J., Whittemore A., Pike M., Darby S. Gonadotrophins and ovarian cancer risk. J Natl Cancer Inst. 1985 Jul;75(1):178–180. [PubMed] [Google Scholar]
  6. Rodriguez M. H., Platt L. D., Medearis A. L., Lacarra M., Lobo R. A. The use of transvaginal sonography for evaluation of postmenopausal ovarian size and morphology. Am J Obstet Gynecol. 1988 Oct;159(4):810–814. doi: 10.1016/s0002-9378(88)80142-x. [DOI] [PubMed] [Google Scholar]
  7. Scott J. S. How to induce ovarian cancer: and how not to. Br Med J (Clin Res Ed) 1984 Sep 29;289(6448):781–782. doi: 10.1136/bmj.289.6448.781. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES